Skip to main content
Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function
Genes and Cancer
  • James I. MacDonald, Western University
  • Frederick A. Dick, Western University
Document Type
Publication Date
URL with Digital Object Identifier

The retinoblastoma tumor suppressor protein (pRB) plays an integral role in G1-S checkpoint control and consequently is a frequent target for inactivation in cancer. The RB protein can function as an adaptor, nucleating components such as E2Fs and chromatin regulating enzymes into the same complex. For this reason, pRB's regulation by posttranslational modifications is thought to be critical. pRB is phosphorylated by a number of different kinases such as cyclin dependent kinases (Cdks), p38 MAP kinase, Chk1/2, Abl, and Aurora b. Although phosphorylation of pRB by Cdks has been extensively studied, activities regulated through phosphorylation by other kinases are just starting to be understood. As well as being phosphorylated, pRB is acetylated, methylated, ubiquitylated, and SUMOylated. Acetylation, methylation, and SUMOylation play roles in pRB mediated gene silencing. Ubiquitinylation of pRB promotes its degradation and may be used to regulate apoptosis. Recent proteomic data have revealed that pRB is posttranslationally modified to a much greater extent than previously thought. This new information suggests that many unknown pathways affect pRB regulation. This review focuses on posttranslational modifications of pRB and how they influence its function. The final part of the review summarizes new phosphorylation sites from accumulated proteomic data and discusses the possibilities that might arise from this data. © The Author(s) 2013.

Citation Information
James I. MacDonald and Frederick A. Dick. "Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function" Genes and Cancer Vol. 3 Iss. 11-12 (2012) p. 619 - 633
Available at: